Drug intelligence / Profile preview

caffeine + curcumin

Development stage
Preclinical
Lead developer
JSS Academy of Higher Education and Research
Modality
Small Molecules
Administration
Topical
01

Overview

**Caffeine + curcumin** is a combination of two small molecule compounds: caffeine, a methylxanthine with central nervous system stimulant and anti-inflammatory activity, and curcumin, a polyphenolic phytochemical from turmeric with notable antioxidant, anti-inflammatory, and antipsoriatic effects. In topical nanosponge gel formulation, this combination has shown **augmented anti-psoriatic activity and faster onset of therapeutic effect compared to curcumin alone**, particularly in a mouse model of imiquimod-induced psoriasis. Mechanistically, caffeine acts primarily as a **phosphodiesterase inhibitor, increasing intracellular cAMP concentrations and suppressing inflammatory pathways**, while curcumin modulates phosphorylase kinase activity, various cell signaling pathways, and receptor-mediated responses, contributing to antitumor and anti-inflammatory actions. The combination is under experimental development for dermatological indications, notably psoriasis.

Other names
caffeine and curcumincurcumin + caffeineCFN + CUR
02

Targets

ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)DNAPDE (Phosphodiesterase family)ADOR (Adenosine receptors)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)PHKA2 (Phosphorylase Kinase)

Beyond the preview

Go deeper on caffeine + curcumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on caffeine + curcumin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call